Electrocore, Inc. key statistics and ratios
In fiscal 2025, Electrocore, Inc. had an operating margin of -41.1% and a current ratio of 1.38. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 36.1% | 41.7% | 51.6% | 50.3% | 74.6% | 81.2% | 82.5% | 85.0% | 86.8% | 87.1% |
| Operating margin | <−999% | <−999% | <−999% | −707.9% | −367.7% | −266.2% | −120.2% | −48.3% | −41.1% | −37.6% |
| Net margin | <−999% | <−999% | <−999% | −672.5% | −315.9% | −257.9% | −117.5% | −47.2% | −43.6% | −40.0% |
| Free-cash-flow margin | <−999% | <−999% | <−999% | — | — | — | −92.8% | — | −25.8% | −26.4% |
| Return on equity | — | — | −100.5% | −99.5% | −57.7% | −82.5% | −153.6% | −158.6% | — | — |
| Return on assets | −91.2% | −99.0% | −82.9% | −70.2% | −46.3% | −65.6% | −92.2% | −65.0% | −71.4% | −82.7% |
| Asset turnover | 0.02 | 0.02 | 0.04 | 0.10 | 0.15 | 0.25 | 0.78 | 1.38 | 1.64 | 2.07 |
| Current ratio | 6.38 | 10.28 | 2.90 | 4.26 | 6.84 | 3.01 | 1.76 | 1.78 | 1.38 | 1.21 |
| Debt to equity | — | 0.0% | 0.0% | 6.1% | — | 1.5% | 3.3% | 0.0% | — | — |
| Interest cover (operating income ÷ interest) | n/m | — | n/m | n/m | — | n/m | — | n/m | n/m | n/m |
| R&D as % of revenue | 965.0% | >999% | 414.3% | 120.2% | 46.5% | 64.2% | 33.2% | 9.4% | 8.5% | 8.5% |
| SG&A as % of revenue | >999% | >999% | >999% | 624.8% | 395.8% | 283.2% | 169.5% | 123.9% | 119.3% | 116.2% |
| Capital spending as % of revenue | 18.8% | 28.1% | 2.9% | — | — | — | 1.3% | — | 0.2% | 0.0% |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 83.8% | 85.9% | 84.9% | 87.3% | 86.0% | 88.4% | 87.3% | 86.5% |
| Operating margin | −40.4% | −43.6% | −56.9% | −47.5% | −33.2% | −31.8% | −55.5% | −29.3% |
| Net margin | −38.1% | −45.8% | −57.4% | −49.7% | −39.2% | −32.8% | −55.0% | −32.4% |
| Free-cash-flow margin | — | — | −65.4% | −8.8% | −19.3% | −16.7% | −31.4% | −37.3% |
| Current ratio | 2.12 | 1.78 | 1.52 | 1.10 | 1.43 | 1.38 | 1.02 | 1.21 |
| R&D as % of revenue | 7.9% | 11.4% | 9.6% | 6.9% | 7.6% | 10.0% | 7.7% | 8.7% |
| SG&A as % of revenue | 116.2% | 118.1% | 132.3% | 127.9% | 111.5% | 110.3% | 135.0% | 107.2% |
Financial health
- Short-term assets cover short-term liabilities $14m of assets due within a year against $12m of liabilities due within a year.
- Short-term assets cover long-term liabilities $14m short-term assets against $8m of longer-dated liabilities.
- More cash than debt $9m of cash against $7m of debt.
- Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt −$10m of operating cash flow against $7m of debt.
- Operating profit covers interest at least five times over Operating income of −$14m against $12,700 of interest.
Moat
Weak moat
How hard Electrocore's competitive advantage looks for rivals to wear away, judged from 9 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 0 / 20
Cash operating profit has been a median -59.6% of total assets over 8 years.
- Pricing power 12 / 20
Gross margin has been a median 80.6%, moving by 18.9 percentage points (standard deviation) across 9 years.
- Durability 10 / 20
Operating margin has been a median -296.5%; its worst year was -3912.9%.
AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.
Compare with peers
- Cytosorbents Corp statistics
- Utah Medical Products Inc statistics
- Retractable Technologies Inc statistics
- Orchestra Biomed Holdings, Inc. statistics
- Myomo, Inc. statistics
Head to head: CTSO vs ECORECOR vs UTMDECOR vs RVP
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies